| Alternative NSN: 6505-01-251-1850 |
| Item Name: Clorazepate Dipotas |
| CAGE Code : 70048 , 0E5C1 , 56287 , 62051 , 60895 , 0MLD2 |
| NIIN: 012511850 |
| NCB Code: USA (01) |
| Manufacturers: abbott laboratories inc , able laboratories inc , actavis inc , danbury pharmacal inc , mylan pharmaceuticals inc , taro pharmaceuticals usa inc |
|
Part No Part No
|
Manufacturer |
Item Name Item Name
|
QTY QTY
|
RFQ RFQ
|
|---|---|---|---|---|
| NDC00074-4390-53 | abbott laboratories inc | clorazepate dipotas | Avl | |
| NDC53265-0049-50 | able laboratories inc | clorazepate dipotas | Avl | |
| NDC00228-3068-50 | actavis inc | clorazepate dipotas | Avl | |
| NDC00591-0364-05 | danbury pharmacal inc | clorazepate dipotas | Avl | |
| NDC00378-0040-05 | mylan pharmaceuticals inc | clorazepate dipotas | Avl | |
| NDC51672-4043-02 | taro pharmaceuticals usa inc | clorazepate dipotas | Avl |
| MRC | Criteria | Characteristic |
|---|---|---|
| AKJA | ACTIVE MEDICAMENT MEDICINAL STRENGTH | 7.500 MILLIGRAMS CLORAZEPATE DIPOTASSIUM ACTIVE INGREDIENT |
| CQCT | PRIMARY CONTAINER TYPE | BOTTLE |
| CRLK | PRIMARY CONTAINER CONTENT QUANTITY | 500.000 TABLETS |
| CXCY | PART NAME ASSIGNED BY CONTROLLING AGENCY | CLORAZEPATE DIPOTASSIUM TABLETS USP 500S BT |
| FEAT | SPECIAL FEATURES | SCHEDULE IV CONTROLLED SUBSTANCE CLASSIFICATION |
| MDES | MEDICAL DESIGNATION AND GRADE | UNITED STATES PHARMACOPEIA |
Before You Go, You Should Consider Looking at Our NSN Parts Catalog. and Remember, ASAP Sourcing Solutions Has Some of the Fastest and Most Competitive Quotes On the Market.
Request for Quote